ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VCEL Vericel Corporation

52.33
0.00 (0.00%)
Pre Market
Last Updated: 08:31:50
Delayed by 15 minutes

Period:

Draw Mode:

Volume 3
Bid Price 52.01
Ask Price 54.86
News -
Day High

Low
28.02

52 Week Range

High
52.43

Day Low
Company Name Stock Ticker Symbol Market Type
Vericel Corporation VCEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 52.33 08:31:50
Open Price Low Price High Price Close Price Prev Close
52.33
Trades Volume Avg Volume 52 Week Range
3 3 - 28.02 - 52.43
Last Trade Time Type Quantity Stock Price Currency
08:19:18 1 $ 52.25 USD

Vericel Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.53B 48.29M - 197.52M -3.18M -0.07 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vericel News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VCEL Message Board. Create One! See More Posts on VCEL Message Board See More Message Board Posts

Historical VCEL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week46.0052.4345.5948.47737,2576.3313.76%
1 Month49.2352.4343.4846.09527,2713.106.30%
3 Months34.1752.4332.3142.47608,63318.1653.15%
6 Months35.7852.4330.1839.52463,34016.5546.25%
1 Year28.9852.4328.0237.20398,21523.3580.57%
3 Years51.3668.9417.3037.30437,1760.971.89%
5 Years17.3468.946.7830.05507,28034.99201.79%

Vericel Description

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

Your Recent History

Delayed Upgrade Clock